Dr. Reddy's Labs Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Jul 1, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-K, foreign-issuer
TL;DR
DRL filed a 6-K, standard foreign issuer report. Nothing major.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on July 1, 2025, reporting for the period ending June 30, 2025. The filing is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company is based in Hyderabad, India, and its fiscal year ends on March 31.
Why It Matters
This filing provides routine updates for investors and regulators regarding Dr. Reddy's Laboratories' status as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-25-000436 (accession_number) — Filing identifier
- 20250630 (date) — Reporting period end date
- 20250701 (date) — Filing date
- 001-15182 (sec_file_number) — SEC file number
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the filing date of this report?
The filing date is July 1, 2025.
What is the reporting period this 6-K covers?
The conformed period of report is June 30, 2025.
Where is Dr. Reddy's Laboratories Limited headquartered?
Dr. Reddy's Laboratories Limited is headquartered in Hyderabad, Telangana, India.
Does Dr. Reddy's Laboratories file an annual report under Form 20-F or 40-F?
The registrant indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 1, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).